Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,761 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Access to cancer drugs in Canada: looking beyond coverage decisions.
Chafe R, Culyer A, Dobrow M, Coyte PC, Sawka C, O'Reilly S, Laing K, Trudeau M, Smith S, Hoch JS, Morgan S, Peacock S, Abbott R, Sullivan T. Chafe R, et al. Among authors: sullivan t. Healthc Policy. 2011 Feb;6(3):27-36. doi: 10.12927/hcpol.2011.22177. Healthc Policy. 2011. PMID: 22294989 Free PMC article.
Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition.
Gelband H, Sankaranarayanan R, Gauvreau CL, Horton S, Anderson BO, Bray F, Cleary J, Dare AJ, Denny L, Gospodarowicz MK, Gupta S, Howard SC, Jaffray DA, Knaul F, Levin C, Rabeneck L, Rajaraman P, Sullivan T, Trimble EL, Jha P; Disease Control Priorities-3 Cancer Author Group. Gelband H, et al. Among authors: sullivan t. Lancet. 2016 May 21;387(10033):2133-2144. doi: 10.1016/S0140-6736(15)00755-2. Epub 2015 Nov 11. Lancet. 2016. PMID: 26578033 Review.
Accessing unfunded cancer drugs in publicly funded hospitals.
Chafe R, Dhalla IA, Dobrow M, Sullivan T. Chafe R, et al. Among authors: sullivan t. Lancet Oncol. 2009 Apr;10(4):306-7. doi: 10.1016/S1470-2045(09)70039-7. Lancet Oncol. 2009. PMID: 19341964 No abstract available.
Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trial.
Bombard Y, Clausen M, Shickh S, Mighton C, Casalino S, Kim THM, Muir SM, Carlsson L, Baxter N, Scheer A, Elser C, Eisen A, Panchal S, Graham T, Aronson M, Piccinin C, Mancuso T, Semotiuk K, Evans M, Carroll JC, Offit K, Robson M, Hamilton JG, Glogowski E, Schrader K, Kim RH, Lerner-Ellis J, Thorpe KE, Laupacis A; Incidental Genomics Study Team. Bombard Y, et al. Genet Med. 2020 Apr;22(4):727-735. doi: 10.1038/s41436-019-0702-z. Epub 2019 Dec 11. Genet Med. 2020. PMID: 31822848 Free PMC article. Clinical Trial.
1,761 results